TreeFrog’s Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM)

– TreeFrog Therapeutics demonstrates fast, sustained, full motor recovery in preclinical models for Parkinson’s Disease cell therapy program using C-Stemâ„¢ proprietary technology[1] – BORDEAUX, France, March 21, 2024 /PRNewswire/ — TreeFrog Therapeutics, a cell therapy development company…